| Financial Year |
March 31 2023 |
| Monetary Funds |
285,613,436.03 |
| Held-for-trading Financial Assets |
121,423,754.90 |
| Notes Receivable |
24,972,367.64 |
| Accounts Receivable |
348,514,970.89 |
| Advances to Suppliers |
9,297,086.82 |
| Other Receivables |
4,487,052.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
189,105,394.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,085,626.49 |
| Total Current Assets |
1,137,186,678.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
42,025,505.32 |
| Fixed Assetes |
378,074,630.88 |
| Under-construction Projects |
62,296,500.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,498,102.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,365,349.57 |
| Other Non-Current Assets |
12,886,539.62 |
| Sub-Total of Non-Current Assets |
571,721,996.88 |
| Total Assets |
1,708,908,675.12 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
107,081,107.92 |
| Accounts Payable |
136,150,939.59 |
| Accounts Received In Advance |
5,173.85 |
| Employee Compensation Payable |
27,467,795.67 |
| Taxes Payable |
5,849,178.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,071,774.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
147,498.62 |
| Sub-Total of Current Liabilities |
315,167,415.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,011,689.62 |
| Other Non-Current Liabilities |
4,882,912.72 |
| Sub-Total of Non-Current Liabilities |
26,935,438.91 |
| Total Liabilities |
342,102,853.91 |
| Paid-In Capital(Or Share Stock) |
165,348,919.00 |
| Capital Surplus |
492,780,376.88 |
| Surplus Reserve |
104,615,527.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
601,742,412.60 |
| Minority Stockholder's Interest |
2,318,585.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,364,487,235.91 |
| Owner's Equity（Stockholder's Equity） |
1,366,805,821.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,708,908,675.12 |
